Enzon Pharmaceuticals Revenue vs. Gross Profit

ENZNDelisted Stock  USD 0.20  0.01  5.26%   
Based on Enzon Pharmaceuticals' profitability indicators, Enzon Pharmaceuticals may not be well positioned to generate adequate gross income at this time. It has a very high probability of underperforming in December. Profitability indicators assess Enzon Pharmaceuticals' ability to earn profits and add value for shareholders.
For Enzon Pharmaceuticals profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Enzon Pharmaceuticals to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Enzon Pharmaceuticals utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Enzon Pharmaceuticals's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Enzon Pharmaceuticals over time as well as its relative position and ranking within its peers.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Please note, there is a significant difference between Enzon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Enzon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Enzon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Enzon Pharmaceuticals Gross Profit vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Enzon Pharmaceuticals's current stock value. Our valuation model uses many indicators to compare Enzon Pharmaceuticals value to that of its competitors to determine the firm's financial worth.
Enzon Pharmaceuticals is rated below average in revenue category among its peers. It is rated below average in gross profit category among its peers fabricating about  1.00  of Gross Profit per Revenue. Comparative valuation analysis is a catch-all model that can be used if you cannot value Enzon Pharmaceuticals by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Enzon Pharmaceuticals' OTC Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Enzon Revenue vs. Competition

Enzon Pharmaceuticals is rated below average in revenue category among its peers. Market size based on revenue of Health Care industry is currently estimated at about 41.85 Million. Enzon Pharmaceuticals claims roughly 701,000 in revenue contributing just under 2% to equities under Health Care industry.

Enzon Gross Profit vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.

Enzon Pharmaceuticals

Revenue

 = 

Money Received

-

Discounts and Returns

 = 
701 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Gross Profit is the most basic measure of business operational efficiency. It is simply the difference between sales revenue and the cost associated with making a product or providing a service. It is calculated before deducting administrative expenses, taxes, and interest payments.

Enzon Pharmaceuticals

Gross Profit

 = 

Revenue

-

Cost of Revenue

 = 
701 K
Gross Profit varies significantly from one sector to another and tells an investor how much money a business would have made if it didn't have to pay any overhead expenses such as salary, taxes, or rent.

Enzon Gross Profit Comparison

Enzon Pharmaceuticals is currently under evaluation in gross profit category among its peers.

Enzon Pharmaceuticals Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Enzon Pharmaceuticals, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Enzon Pharmaceuticals will eventually generate negative long term returns. The profitability progress is the general direction of Enzon Pharmaceuticals' change in net profit over the period of time. It can combine multiple indicators of Enzon Pharmaceuticals, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Enzon Pharmaceuticals, Inc., together with its subsidiaries, engages in marketing drug products. The company was founded in 1981 and is headquartered in Cranford, New Jersey. Enzon Pharma operates under Biotechnology classification in the United States and is traded on OTC Exchange.

Enzon Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Enzon Pharmaceuticals. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Enzon Pharmaceuticals position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Enzon Pharmaceuticals' important profitability drivers and their relationship over time.

Use Enzon Pharmaceuticals in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Enzon Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enzon Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.

Enzon Pharmaceuticals Pair Trading

Enzon Pharmaceuticals Pair Trading Analysis

The ability to find closely correlated positions to Enzon Pharmaceuticals could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Enzon Pharmaceuticals when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Enzon Pharmaceuticals - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Enzon Pharmaceuticals to buy it.
The correlation of Enzon Pharmaceuticals is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Enzon Pharmaceuticals moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Enzon Pharmaceuticals moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Enzon Pharmaceuticals can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Enzon Pharmaceuticals position

In addition to having Enzon Pharmaceuticals in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Large & Mid Caps ETFs Thematic Idea Now

Large & Mid Caps ETFs
Large & Mid Caps ETFs Theme
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Large & Mid Caps ETFs theme has 41 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Large & Mid Caps ETFs Theme or any other thematic opportunities.
View All  Next Launch
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in nation.
Note that the Enzon Pharmaceuticals information on this page should be used as a complementary analysis to other Enzon Pharmaceuticals' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.

Other Consideration for investing in Enzon OTC Stock

If you are still planning to invest in Enzon Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Enzon Pharmaceuticals' history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Fundamental Analysis
View fundamental data based on most recent published financial statements
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance